Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Network-1 Sec Solu (NY: NTIP )

1.370 -0.010 (-0.72%)
Official Closing Price Updated: 8:00 PM EDT, Oct 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24,283
Open 1.370
Bid (Size) 1.350 (5)
Ask (Size) 1.740 (1)
Prev. Close 1.380
Today's Range 1.370 - 1.400
52wk Range 1.360 - 2.340
Shares Outstanding N/A
Dividend Yield 7.30%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Network-1 Subsidiary Receives New Patent from U.S. Patent Office Expanding Its HFT Patent Portfolio to Include 10 Issued U.S. Patents
Via ACCESSWIRE
Network-1 Declares Semi-Annual Dividend
Via ACCESSWIRE

Performance

YTD
-36.28%
-36.28%
1 Month
-11.90%
-11.90%
3 Month
-11.61%
-11.61%
6 Month
-34.13%
-34.13%
1 Year
-39.65%
-39.65%

More News

Read More
NTIP Stock Earnings: Network-1 Technologies Reported Results for Q2 2024
Via InvestorPlace
Network-1 Reports Second Quarter Results
Via ACCESSWIRE
NTIP Stock Earnings: Network-1 Technologies Reported Results for Q1 2024
Via InvestorPlace
Network-1 Reports First Quarter 2024 Results
Via ACCESSWIRE
Network-1 Reports 2023 Year-End Financial Results
Via ACCESSWIRE
Press release 58740 - See attachment
Via ACCESSWIRE
Network-1 Reports Second Quarter Results
Via ACCESSWIRE
7 Monster Growth Stocks to Turn $7K into $70k
Via InvestorPlace
NTIP Stock Earnings: Network-1 Technologies Reported Results for Q4 2023
Via InvestorPlace
Network-1 Receives New Patent from U.S. Patent Office Expanding Its M2M/IoT Patent Portfolio to 51 Patents Worldwide
Via ACCESSWIRE
Network-1 Declares Semi-Annual Dividend
Via ACCESSWIRE
Network-1 Declares Semi-Annual Dividend
Via ACCESSWIRE
ILiAD Biotechnologies Reports First-ever Demonstration of Protection Against B. pertussis Colonization in Phase 2b Human Challenge Study of BPZE1 Vaccine
Via ACCESSWIRE
Network-1 Reports First Quarter 2023 Results
Via ACCESSWIRE
Network-1 Reports 2022 Year-End Financial Results
Via ACCESSWIRE
Network-1 Receives New eSIM Patent from U.S. Patent Office Expanding Its M2M/IoT Patent Portfolio to 50 Patents Worldwide
Via ACCESSWIRE
Network-1 Declares Semi-Annual Dividend
Via ACCESSWIRE
Network-1 Subsidiary Receives New Patent from U.S. Patent Office Expanding its HFT Patent Portfolio to Include 9 Issued U.S. Patents
Via ACCESSWIRE
Network-1 Reports Third Quarter Results
Via ACCESSWIRE
Network-1 Declares Semi-Annual Dividend
Via ACCESSWIRE
CORRECTION: Network-1 Reports Second Quarter Results
Via ACCESSWIRE
Network-1 Reports Second Quarter Results
Via ACCESSWIRE
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.